LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
24h
Corrente
Minimo
217.51
Massimo
217.99
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | -10.28% downside |
By Acuity
58%
42%
147 / 374 Classifica in Healthcare
By Trading Central
Fiducia
Bearish Evidence
18.88 / 19.67 Supporto e resistenza
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
14 nov 2025, 12:31 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal -- Update
DJ
LeggI
14 nov 2025, 12:16 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
DJ
LeggI
14 nov 2025, 11:20 UTC
Cidara Shares Nearly Double Premarket on Report of Takeover by Merck
DJ
LeggI
14 nov 2025, 11:11 UTC
Merck Nears $9.2 Billion Deal for Cidara, FT Reports, Citing Sources
DJ
LeggI
23 giu 2025, 12:05 UTC
Cidara Shares Soar Premarket After Positive Influenza Trial Results
DJ
LeggI
14 nov 2025, 16:30 UTC
Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com
DJ
LeggI
14 nov 2025, 13:19 UTC
This Biotech Stock Is Soaring 100%. Merck Is Buying It. -- Barrons.com
DJ
LeggI
14 nov 2025, 12:22 UTC
Pharma Sector Becoming Bidding Battlefield -- Market Talk
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 195.33 USD -10.28%
Alto 221.5 USD
Basso 167 USD
Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per CIDARA THERAPEUTICS INC - Dist negli ultimi 3 mesi.
By TipRanks
Acquista
8 ratings
4
Acquista
4
Mantieni
0
Vendi
Basato sugli analisti di 8 che hanno fornito valutazioni azionarie a CIDARA THERAPEUTICS INC - Dist negli ultimi 3 mesi.
By Trading Central
A breve termine
Bearish Evidence
Recent bearish events outweigh bullish events.
A termine intermedio
Strong Bearish Evidence
All events are bearish.
A lungo termine
Strong Bullish Evidence
All events are bullish.
By Acuity
Notizie sul Sentiment di mercato
Prove ribassiste
Volatilità
Sotto la media
Volume delle notizie (RCV)
Sopra la media
$